Graduate Students

Welcome New Cancer Biology Students

 Zuo Ding


Lab of Shuang Huang, Ph.D.



Mai Tanaka


Lab of Dietmar Siemann, Ph.D.

My work in Dr. Dietmar Siemann’s lab focuses on understanding the Gas6/Axl signaling pathway that is dysregulated in many cancers and promotes metastatic phenotype. We believe that this signaling pathway is a promising therapeutic target to inhibit the dissemination of cells and to ultimately reduce cancer mortality

Kartika Venugopal

Lab of Olga Guryanova, M.D., Ph.D.

My project investigates the efficacy of DNA replication targeting drugs in Acute Myeloid Leukemia with DNMT3A mutation.



Aaron Waddell


Lab of Daiqing Liao, Ph.D.

CBP/p300 are highly related acetyltransferases that acetylate chromatin and serve as co-activators for genes involved in cancer. The Liao Lab uses molecular, cellular and chemical biological approaches to understand roles of CBP/p300 in cancer biology and to develop small molecule inhibitors of CBP/p300 enzymatic activity for cancer therapy.


The Cancer Biology Concentration provides training opportunities in cancer research ranging from basic to translational. The program spans many disciplines, including molecular and cell biology, genetics and epigenetics, biochemistry, microbiology, pharmacology, anatomy, pathology, epidemiology, bioinformatics, immunology and many others involved in the understanding of the development, progression, dissemination, and treatment of cancer.

The Goal of the Cancer Biology Concentration is to utilize molecular, cellular, biochemical, and host experimental approaches develop new knowledge that will enhance our understanding of cancer that will translate into improved detection, prevention and treatment of this disease.

The Mission of the Cancer Biology Concentration is to train the next generation of cancer biologists to make significant contributions to basic and translational research in cancer prevention and diagnosis, cancer epidemiology, novel therapy discovery, and cancer treatment.

Learn More …